Helix Acquisition Corp Contracts & Agreements
64 Contracts & Agreements
- Business Finance (35 contracts)
- Business Operations (5)
- Human Resources (9)
- Intellectual Property (3)
- Uncategorized (12)
- Description of Securities (Filed With SEC on February 29, 2024)
- Amended and Restated Employee Share Participation Plan of MoonLake Immunotherapeutics AG, dated June 15, 2023 (Filed With SEC on August 10, 2023)
- Amended and Restated Employee Stock Option Plan of MoonLake Immunotherapeutics AG, dated June 15, 2023 (Filed With SEC on August 10, 2023)
- Novation, Amended and Restatement of License Agreement, dated June 1, 2023, between MoonLake Immunotherapeutics AG, Research Corporation Technologies, Inc. and Merck KGaA (Filed With SEC on August 10, 2023)
- MoonLake Immunotherapeutics Underwriting Agreement (Filed With SEC on June 29, 2023)
- Sales Agreement, dated May 11, 2023, between MoonLake Immunotherapeutics and SVB Securities LLC (Filed With SEC on May 11, 2023)
- Form of Nonqualified Stock Option Agreement (Filed With SEC on March 20, 2023)
- Description of Securities (Filed With SEC on March 20, 2023)
- Clinical and Commercial Manufacturing Agreement, dated April 11, 2022, effective July 1, 2021, by and between MoonLake Immunotherapeutics AG and Richter-Helm Biologics GmbH & Co.... (Filed With SEC on May 2, 2022)
- Form of Subscription Agreement (Filed With SEC on May 2, 2022)
- Form of Non-Employee Director Stock Option Agreement (Filed With SEC on April 11, 2022)
- MoonLake Immunotherapeutics 2022 Equity Incentive Plan (Filed With SEC on April 11, 2022)
- Form of Subscription Agreement (Filed With SEC on April 11, 2022)
- Amended and Restated Registration Rights Agreement, dated as of April 5, 2022, by and among the MoonLake Immunotherapeutics, Helix Holdings LLC and the holders signatory thereto (Filed With SEC on April 11, 2022)
- Amended and Restated Shareholders Agreement, dated as of April 5, 2022, by and among MoonLake Immunotherapeutics, MoonLake Immunotherapeutics AG and the investors signatory thereto (Filed With SEC on April 11, 2022)
- Promissory Note (Filed With SEC on March 24, 2022)
- Assignment of Contract Manufacturing Agreement, dated July 1, 2021, by and among MoonLake Immunotherapeutics AG, MERCK Healthcare KGaA, and Richter-Helm Biologics GmbH & Co (Filed With SEC on March 14, 2022)
- Amendment No. 2 to Contract Manufacturing Agreement, by and between MoonLake Immunotherapeutics AG, as assignee of MERCK Healthcare KGaA, and Richter-Helm Biologics GmbH & Co (Filed With SEC on March 14, 2022)
- Contract Manufacturing Agreement, dated October 15, 2018, by and between MoonLake Immunotherapeutics AG, as assignee of MERCK Healthcare KGaA, and Richter-Helm Biologics GmbH & Co (Filed With SEC on March 14, 2022)
- Side Letter to License Agreement, dated April 29, 2021, by and between MoonLake Immunotherapeutics AG and MERCK Healthcare KGaA (Filed With SEC on March 14, 2022)
- License Agreement, dated April 29, 2021, by and between MoonLake Immunotherapeutics AG and MERCK Healthcare KGaA (Filed With SEC on March 14, 2022)
- Amendment to Employment Agreement, dated September 9, 2021, by and between MoonLake Immunotherapeutics AG and Jonkheer Arnout Michiel Ploos van Amstel (Filed With SEC on March 8, 2022)
- Form of Indemnification Agreement for directors and executive officers (Filed With SEC on March 8, 2022)
- Second Amendment to the Loan Agreement, dated February 15, 2022, by and among MoonLake Immunotherapeutics AG and the Lenders named therein (Filed With SEC on March 8, 2022)
- Amendment to the Loan Amendment, dated January 18, 2022, by and among MoonLake Immunotherapeutics AG and the Lenders named therein (Filed With SEC on March 8, 2022)
- Loan Agreement, dated October 15, 2021, by and among MoonLake Immunotherapeutics AG and the Lenders named therein (Filed With SEC on March 8, 2022)
- Employee Stock Option Plan of MoonLake Immunotherapeutics AG, dated December 14, 2021 (Filed With SEC on March 8, 2022)
- Employee Share Participation Plan of MoonLake Immunotherapeutics AG, dated December 14, 2021 (Filed With SEC on March 8, 2022)
- Employee Stock Option Plan of MoonLake Immunotherapeutics AG, dated July 23, 2021 (Filed With SEC on March 8, 2022)
- Employee Share Participation Plan of MoonLake Immunotherapeutics AG, dated July 23, 2021 (Filed With SEC on March 8, 2022)
- Board Member Agreement, dated September 25, 2021, by and between MoonLake Immunotherapeutics AG and Simon Sturge (Filed With SEC on March 8, 2022)
- Termination Agreement, dated December 13, 2021, by and between MoonLake Immunotherapeutics AG and Jonkheer Arnout Michiel Ploos van Amstel (Filed With SEC on March 8, 2022)
- Employment Agreement, dated April 30, 2021, by and between MoonLake Immunotherapeutics AG and Jonkheer Arnout Michiel Ploos van Amstel (Filed With SEC on March 8, 2022)
- Amendment to Employment Agreement, dated June 22, 2021, by and between MoonLake Immunotherapeutics AG and Matthias Bodenstedt (Filed With SEC on March 8, 2022)
- Employment Agreement, dated May 10, 2021, by and between MoonLake Immunotherapeutics AG and Matthias Bodenstedt (Filed With SEC on March 8, 2022)
- Amendment to Employment Agreement, dated November 8, 2021, by and between MoonLake Immunotherapeutics AG and Prof. Dr. Kristian Reich (Filed With SEC on March 8, 2022)
- Employment Agreement, dated April 30, 2021, by and between MoonLake Immunotherapeutics AG and Prof. Dr. Kristian Reich (Filed With SEC on March 8, 2022)
- Amendment to Employment Agreement, dated September 9, 2021, by and between MoonLake Immunotherapeutics AG and Dr. Jorge Santos da Silva (Filed With SEC on March 8, 2022)
- Employment Agreement, dated April 30, 2021, by and between MoonLake Immunotherapeutics AG and Dr. Jorge Santos da Silva (Filed With SEC on March 8, 2022)
- Convertible Loan Agreement, dated as of February 20, 2022, by and among Cormorant Private Healthcare Fund IV. L.P., MoonLake Immunotherapeutics AG, Biotechnology Value Fund, L.P.,... (Filed With SEC on February 25, 2022)
- Description of Securities (Filed With SEC on February 17, 2022)
- Form of Amended and Restated Registration Rights Agreement (Filed With SEC on October 4, 2021)
- Amended Sponsor Agreement, dated as of October 4, 2021, by and among Helix Acquisition Corp., Helix Holdings LLC, and the officers and directors of Helix Acquisition Corp (Filed With SEC on October 4, 2021)
- Form of Subscription Agreement (Filed With SEC on October 4, 2021)
- Form of Amended and Restated Shareholders Agreement (Filed With SEC on October 4, 2021)
- Investment Agreement, dated as of October 4, 2021, by and among Helix Acquisition Corp., MoonLake Immunotherapeutics AG and the existing shareholders and option rights holders of... (Filed With SEC on October 4, 2021)
- Business Combination Agreement, dated as of October 4, 2021, by and among Helix Acquisition Corp., MoonLake Immunotherapeutics AG, the existing shareholders and option rights... (Filed With SEC on October 4, 2021)
- Description of Securities (Filed With SEC on March 31, 2021)
- Administrative Services Agreement, dated October 19, 2020, between the Company and Helix Holdings LLC (Filed With SEC on October 22, 2020)
- Private Placement Class A Ordinary Shares Purchase Agreement, dated October 19, 2020, between the Company and Helix Holdings LLC (Filed With SEC on October 22, 2020)
- Registration Rights Agreement, dated October 19, 2020, among the Company, Helix Holdings LLC and the Holders signatory thereto (Filed With SEC on October 22, 2020)
- Investment Management Trust Agreement, dated October 19, 2020, between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on October 22, 2020)
- Letter Agreement, dated October 19, 2020, among the Company, Helix Holdings LLC and each of the officers and directors of the Company (Filed With SEC on October 22, 2020)
- Underwriting Agreement, dated October 19, 2020, between the Company and Jefferies LLC (Filed With SEC on October 22, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 14, 2020)
- Form of Administrative Services Agreement between the Registrant and Helix Holdings LLC (Filed With SEC on October 14, 2020)
- Securities Subscription Agreement between Helix Holdings LLC and the Registrant (Filed With SEC on October 14, 2020)
- Promissory Note issued to Helix Holdings LLC (Filed With SEC on October 14, 2020)
- Form of Indemnity Agreement (Filed With SEC on October 14, 2020)
- Form of Private Placement Shares Purchase Agreement among the Registrant and Helix Holdings LLC (Filed With SEC on October 14, 2020)
- Form of Registration Rights Agreement among the Registrant, Helix Holdings LLC and the Holders signatory thereto (Filed With SEC on October 14, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 14, 2020)
- Form of Letter Agreement among the Registrant, Helix Holdings LLC and each of the officers and directors of the Registrant (Filed With SEC on October 14, 2020)
- Specimen Ordinary Share Certificate (Filed With SEC on October 14, 2020)